(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. - Wikidata - awgldk - TriplyDB

(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

http://www.wikidata.org/entity/Q34993694

about

Recent updates of precision therapy for gastric cancer: Towards optimal tailored management Cancer prevention with promising natural products: mechanisms of action and molecular targets Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor Chemoprevention of gastrointestinal cancer: the reality and the dream.Pancreatic cancer chemoprevention by phytochemicals Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects.Preparation of epigallocatechin gallate-loaded nanoparticles and characterization of their inhibitory effects on Helicobacter pylori growth in vitro and in vivo.Targeting STAT3 in gastric cancer.Green tea catechins: a fresh flavor to anticancer therapy.Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade.Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.Effects of caffeic acid phenethyl ester on matrix molecules and angiogenetic and anti-angiogenetic factors in gastric cancer cells cultured on different substrates.(-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.Necl 4 and RNase 5 Are Important Biomarkers for Gastric and Colon Adenocarcinomas.Antiangiogenic Effect of Flavonoids and Chalcones: An Update.

P2860

Q26746246-A1C4E38D-90DB-4A0A-B367-F15CECD5DBBA Q27006530-6FD445EA-731F-4721-85B4-9CF0313C939F Q27022976-D650204B-C77B-4578-B7C3-F41EDBCDA1F1 Q36715105-06C27F35-236D-49C9-9BCE-946759C53A52 Q36763100-63195378-9C15-46F3-BB0A-684A58FFF233 Q37214530-73C82A9E-AD56-4901-874C-1D65875FACCA Q37387057-C265FA90-23CD-4C14-A9A7-E9DE50006096 Q38029729-D85767D3-E67E-4390-9824-D75E5D49FE6C Q38147993-C7BA17D4-38D4-405F-BAF3-66028AD91D0F Q38175845-C08D4B59-1B4F-4B82-B8DB-8BFB1903D125 Q38794840-1F54CFA0-E82F-40B8-B01E-0AF25A800FAE Q38822991-60FE11BE-265B-4ED7-A2C2-BB54C0EC4624 Q38930822-38755EFB-DF61-40E4-B23D-AFAC11CF3FBD Q38958946-24FDBB36-1788-4078-8E92-397966A3C4F7 Q38965315-28A59C03-042D-44D0-AB7F-45DD13AEA154 Q39215796-B4FC22E3-2E5D-475C-97D0-AFDF5C22D986 Q42217300-9C131E81-1A77-42A9-A1DC-6FA6FF319DDD Q50043004-BCFB3BAC-009C-4B46-AED1-7C532A8DCAF3

P2860

(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

http://www.wikidata.org/entity/Q34993694

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.

@ast

(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.

@en

type

label

(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.

@ast

(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.

@en

prefLabel

(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.

@ast

(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.

@en

P1433

Q34993694-75CA62A4-28F9-46A3-A0F9-0CDA71A2A78E

P1476

Q34993694-22F3824C-A3E8-4AFC-B77E-ECFD624CA333

P2093

Q34993694-0D23B287-F84A-4F3E-8DA3-BE823EB657B9

Q34993694-737F83D3-2637-4E82-A78D-320E1D44D902

Q34993694-7A80E2BA-B023-4C24-9721-D33D9A70DD13

Q34993694-9216D02F-7F02-4E96-A7E9-6254521D99F5

Q34993694-B94D66A0-DB19-4779-82AA-1554F7606729

Q34993694-D1028787-0AA3-4BFE-BEA7-76EF4405CDDE

Q34993694-D5122F78-4973-48A9-9E01-1E8AFE886665

Q34993694-F43E53C3-BD36-4289-8ADB-06513CF84EEF

P2860

Q34993694-0C838D94-73DC-438C-85D4-E024471947B8

Q34993694-11058F3D-5F1A-4E44-8CB7-377FA3330F8F

Q34993694-18900821-37FE-4F79-B540-0DB3D334C06E

Q34993694-1CD05ABE-47D1-4710-904B-F7EE3A52DFC8

Q34993694-2AC44EAF-0708-48EE-AB34-2057B3404FF6

Q34993694-36B78118-6136-47DD-8235-A2755BD86CA7

Q34993694-39ED9ED9-1FFD-413D-BF09-E88FF6F34871

Q34993694-408D5B29-7D37-4621-8F1D-EBE2F3B0BB3E

Q34993694-4D91A2B2-0F2B-46C3-989E-4657D8551C97

Q34993694-4EF64945-3338-40C1-AA5F-EEFDA4DCC281

P304

Q34993694-2BD0F28D-B5B3-4C25-8ACE-6127E0D1BFCF

P31

Q34993694-9BCA5001-0A0B-4CEF-861C-00500D2E9FAF

P356

Q34993694-ADC84EC1-39E3-461C-9CD0-F892DB7E8D4C

P407

Q34993694-C2D34DAB-F6AD-4EB9-B9F0-25F8DA1EFCC4

P433

Q34993694-33120CA9-1442-44A4-95D0-D54F07DF2ECB

P478

Q34993694-C927860E-40E1-4DF9-A720-6C30853D8C01

P577

Q34993694-3A145E76-E7A5-4746-94FE-A35674141B2A

P5875

Q34993694-006BE1DE-7E07-4A2F-A934-68D93E1B78DF

P698

Q34993694-A0264A6B-392F-4886-ABA5-754778A4DCDA

P932

Q34993694-A79620AD-4B3B-4772-8E73-FDC0BF7424E7

P356

WJG.V17.I18.2315

P1433

World Journal of Gastroenterology

P1476

(-)-Epigallocatechin-3-gallate ...... 6 via Stat3 in gastric cancer.

@en

P2093

Bao-He Zhu

http://www.w3.org/2001/XMLSchema#string

Chang-Hua Zhang

http://www.w3.org/2001/XMLSchema#string

Cheng-You Wang

http://www.w3.org/2001/XMLSchema#string

Hua-Yun Chen

http://www.w3.org/2001/XMLSchema#string

Shi-Rong Cai

http://www.w3.org/2001/XMLSchema#string

Wen-Hua Zhan

http://www.w3.org/2001/XMLSchema#string

Yu-Long He

http://www.w3.org/2001/XMLSchema#string

Zhao Wang

http://www.w3.org/2001/XMLSchema#string

P2860

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.

Cellular and molecular aspects of gastric cancer.

(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.

Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Multitargeted therapy of cancer by green tea polyphenols.

Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.

Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.

Constitutive and inducible expression and regulation of vascular endothelial growth factor.

P304

2315-2325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V17.I18.2315

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51184870

http://www.w3.org/2001/XMLSchema#string

P698

21633597

http://www.w3.org/2001/XMLSchema#string

P932

3098399

http://www.w3.org/2001/XMLSchema#string